Individualized Neuromuscular Quality of Life Questionnaire (INQLQ-45)

Description

The Individualized Neuromuscular Quality of Life Questionnaire (INQLQ-45) is a specialized psychometric instrument designed to assess the quality of life of individuals living with neuromuscular disorders. It is intended for patients with conditions such as muscular dystrophy, amyotrophic lateral sclerosis (ALS), hereditary neuropathies, myopathies, and other disorders affecting the neuromuscular system.

The INQLQ-45 consists of 45 items that comprehensively evaluate the impact of neuromuscular disease on multiple aspects of everyday life while taking into account each patient’s individual needs, priorities, and personal experiences. Unlike generic quality-of-life questionnaires, the INQLQ-45 focuses specifically on disease-related challenges, providing a more personalized and clinically meaningful assessment of patient well-being.

The questionnaire evaluates several key domains, including:

  • physical functioning,
  • emotional well-being,
  • social interaction,
  • level of independence,
  • pain and physical discomfort,
  • daily functioning,
  • the impact of the disease on everyday activities, and
  • overall quality of life.

The instrument is widely applicable in neurology, physical and rehabilitation medicine, physiotherapy, occupational therapy, clinical psychology, and neuromuscular research. It serves as an important outcome measure for clinical assessment, rehabilitation planning, and longitudinal monitoring of disease progression.

Analysis and Use of Data

Analysis of the Individualized Neuromuscular Quality of Life Questionnaire (INQLQ-45) involves calculating overall and domain-specific scores that reflect the extent to which neuromuscular disease affects different aspects of an individual’s quality of life.

The resulting scores enable clinicians and researchers to identify the areas most affected by the disease, monitor disease progression, evaluate treatment effectiveness, and assess outcomes of rehabilitation and supportive care interventions.

In research settings, INQLQ-45 scores may be examined in relation to numerous clinical and psychosocial variables, including:

  • functional mobility,
  • muscle strength,
  • independence in activities of daily living,
  • fatigue,
  • chronic pain,
  • depression,
  • anxiety,
  • psychological well-being,
  • social support,
  • sleep quality,
  • treatment adherence,
  • overall quality of life,
  • disease progression, and
  • therapeutic outcomes.

The psychometric evaluation of the instrument typically includes assessments of internal consistency using Cronbach’s alpha, as well as Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) to examine construct validity. Depending on the objectives of the study, additional statistical procedures may include correlation analysis, multiple linear regression, logistic regression, independent-samples t-tests, ANOVA, MANOVA, mediation and moderation analyses, and Structural Equation Modeling (SEM) to investigate relationships between quality of life and clinical, functional, or psychological variables.

Purpose

The primary purpose of the Individualized Neuromuscular Quality of Life Questionnaire (INQLQ-45) is to provide a reliable and valid assessment of the quality of life of individuals affected by neuromuscular disorders while taking into consideration their unique functional limitations, personal priorities, and everyday experiences.

The questionnaire assists healthcare professionals in identifying the most significant consequences of neuromuscular disease, developing individualized treatment and rehabilitation plans, and evaluating the effectiveness of therapeutic interventions over time. Furthermore, it serves as an important research instrument in clinical trials, epidemiological studies, and outcome research involving neuromuscular diseases.

Scoring

The INQLQ-45 consists of 45 items, each rated using Likert-type response scales that allow respondents to evaluate the extent to which their neuromuscular condition affects different aspects of daily life.

Responses are scored according to the standardized administration guidelines to produce overall and domain-specific quality-of-life scores. Depending on the scoring protocol, higher or lower scores reflect different levels of functional impairment, independence, emotional well-being, and overall quality of life. Interpretation of the results should always follow the original scoring procedures established by the developers of the instrument.

The psychometric properties of the questionnaire are commonly evaluated through internal consistency using Cronbach’s alpha, while Confirmatory Factor Analysis (CFA) and cross-validation procedures are employed to ensure construct validity and the applicability of the instrument across different patient populations and clinical settings.

References

Abresch, R. T., Carter, G. T., Jensen, M. P., & Kilmer, D. D. (2002). Assessment of Quality of Life in Neuromuscular Disease. American Journal of Physical Medicine & Rehabilitation, 81(3), 162–171.

Hobart, J. C., & Cano, S. J. (2009). Improving the Evaluation of Therapeutic Interventions in Multiple Sclerosis: The Role of New Psychometric Methods. Health Technology Assessment, 13(12), iii, ix–x, 1–177.

Carter, G. T., & Abresch, R. T. (2004). Quantitative Measures and Clinical Trial Design in Neuromuscular Disease. Physical Medicine and Rehabilitation Clinics of North America, 15(4), 951–969.